Best Alcohol and Drug Rehab NJ in Branchville, NJ

Jeffrey A. Berman, MD, FASAM is a Diplomate and Fellow of the American Society of Addiction Medicine. He is the Executive Medical Director of Discovery Institute for Addictive Disorders in Marlboro, NJ and Clinical Assistant Professor of Psychiatry at the Robert Wood Johnson Medical School. He was recruited from Bergen Regional Medical Center, NJ’s largest acute psychiatric hospital, where he served as Director of Chemical Dependency Services to join Discovery Institute in Marlboro. Dr. Berman is a diplomate of the American Board of Psychiatry and Neurology (ABPN) in Adult and Addiction Psychiatry as well as Psychosomatic Medicine. He has been certified by the American Society of Addiction Medicine since 1988 and is Board Certified in Addiction Medicine (ABAM). Dr. Berman’s area of special interest in research and teaching is Pain Management and Co-occurring Opioid Dependence. He is also a strong advocate for Medication Assisted Treatment (MAT) for the chronic persistent mentally ill. Dr. Berman participated in NIDA’s clinical trials of Buprenorphine/Naloxone for treatment of heroin addiction in 2001. Since then he has developed innovative treatment programs for individuals with Co-occurring disorders as well as Substance Use Disorders. Dr. Berman served as Chief of Psychiatry at Fort Leavenworth, KS including the Department of Defense’s US Disciplinary Barracks located at Fort Leavenworth. He recently retired from the US Army Reserve after 22 years of service which included service in Operations Desert Storm and Iraqi Freedom. He is currently the Psychiatric Consultant to the Department of Immigration Health (DIHS), a division of Homeland security. Prior to coming to New Jersey, he served as Medical Director of Gieisinger Health Care’s Marworth chemical dependency center and consultant to pain management centers in New Jersey and Pennsylvania for issues of addiction, pain and co-occurring mood disorders. He has taken an active role in the medical treatment of HIV patients in all of these clinical settings.

William D Stanley, born and raised in Baltimore, MD, attended UMDNJ-Robert Wood Johnson Medical school. Later, he did his internship and residency at Albert Einstein Med Center in Philadelphia. Initially, he practiced primary care for many years but due to the influence of many people—in particular, Dr. Lou Baxter—his eyes gravitated to the world of substance abuse. Dr. Stanley became certified by the American Board of Addiction Medicine in 2000. He initially focused on outpatient treatment of opioid dependence with Suboxone and, more recently, Vivitrol. He was invited to join the family of Summit Behavioral Health in 2013 part-time and started full-time as the medical director of their detox in December 2014.

Robert Snyder has been working in the field of substance abuse for ten years. He has experience in residential and outpatient settings, and has helped a wide variety of people battle addiction, including both adults and adolescents. He received his Master’s degree, LCADC and CCS in 2013. He teaches assessment skills for addiction studies as an adjunct professor at Atlantic Cape Community College. As a person in longterm recovery, Robert is active in his community and has a passion for helping others attain positive change in their lives.